Mumbai: Mubadala Investment Company on Monday announced that it is investing in Manipal Health Enterprise(Manipal). Temasek, a Singapore-headquartered global investment company, will continue to hold a majority stake in Manipal.
“Manipal distinguishes itself through its commitment to clinical excellence, its strong patient-centric approach, and its impeccable standards of corporate governance,” said Camilla Macapili Languille, Head of Life Sciences at Mubadala. “Given the ever-increasing demand for high-quality hospital care across India, we look forward to supporting Manipal’s growth journey in the years ahead.”
“We are delighted to work with such high-quality partners like Temasek, TPG, Dr Ranjan Pai and the management team of Manipal to drive the business through the next phase of its growth trajectory,” said Luca Molinari, Head of Asia, Direct Investments, at Mubadala. “Manipal is playing a significant role in developing India’s national healthcare infrastructure and we are tremendously excited to partner with them.”